Press release
Growing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Antimicrobial Resistance: A Significant Driver Propelling The Cephalosporin Drugs Market In 2025
Cephalosporin Drugs
What Is the Cephalosporin Drugs Market Size and Projected Growth Rate?
In recent times, there has been consistent growth in the market size of cephalosporin drugs. The market is predicted to increase from $16.56 billion in 2024 to $17.34 billion in 2025, with a compound annual growth rate (CAGR) of 4.7%. Factors contributing to this growth during the historic period include a rising prevalence of bacterial infections, the growth of antibiotic resistance, an increase in healthcare spending, and a growing demand for generic drugs.
There is predicted to be a consistent expansion in the cephalosporin drugs market in the upcoming years, reaching a valuation of $20.64 billion in 2029, with a compound annual growth rate (CAGR) of 4.4%. The surge in the estimated period is driven by factors such as increasing elderly population, heightened awareness about bacterial infection, growing hospital admissions, and the enhancement of new cephalosporin formulations. The forecast period's key trends encompass progress in drug formulation techniques, technology incorporation in manufacturing procedures, the creation of novel cephalosporin derivatives, and advancements in medication delivery systems.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24187&type=smp
What Are the Major Segments in the Cephalosporin Drugs Market?
The cephalosporin drugs market covered in this report is segmented -
1) By Generation: First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation
2) By Route of Administration: Oral, Parenteral, Topical
3) By Application: Skin Infection, Respiratory Tract Infection, Urinary Tract Infection
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By First Generation: Cefazolin, Cephradine, Cephalexin
2) By Second Generation: Cefuroxime, Loracarbef, Cefaclor, Cefprozil
3) By Third Generation: Ceftriaxone, Cefdinir, Cefotaxime, Ceftazidime
4) By Fourth Generation: Cefepime, Cefpirome
5) By Fifth Generation: Ceftaroline, Ceftobiprole
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24187&type=smp
What Are The Driving Cephalosporin Drugs Market Evolution?
The rise in infectious diseases is anticipated to fuel the expansion of the cephalosporin drugs market. These diseases are caused by pathogens like bacteria, viruses, fungi, or parasites, and can be transmitted from one person to another. The escalation in infectious diseases is attributed to the increasing antimicrobial resistance, making formerly curable infections harder to treat, thereby resulting in more pervasive and persistent diseases. The broad-spectrum antibacterial properties of cephalosporin drugs make them useful in battling myriad bacterial infections. They offer rapid and dependable relief, cutting down treatment time, and consequently enhancing patient recovery. To illustrate, in November 2023, the Department of Health and Human Services, a US government department, reported an 11% rise in new chronic hepatitis B (a viral infection impacting the liver that can culminate in either acute or chronic disease) cases in 2022 versus 2021. Thus, the escalating occurrence of infectious diseases is propelling the growth of the cephalosporin drugs market.
Which Firms Dominate The Cephalosporin Drugs Market Segments?
Major companies operating in the cephalosporin drugs market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Baxter International, Macleods Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Mankind Pharma Limited, Aristo Pharmaceuticals Ltd, Hetero Drugs Ltd, Covalent Laboratories Private Limited.
What Are the Latest Developing Trends in the Cephalosporin Drugs Market?
Prominent companies in the cephalosporin drugs market are prioritizing the creation of innovative solutions, such as treatments for gram-negative bacterial infections, in an effort to combat the increasing global issue of antimicrobial resistance and drug-resistant infections. Treatments for gram-negative bacterial infections involve the use of specific antibiotics to counteract gram-negative bacteria, characterized by their unique cell wall structure which makes them highly resistant to a majority of conventional antibiotics. For example, in May 2024, Shionogi & Co. Ltd., a pharmaceutical company based in Japan, introduced FETROJA (Cefiderocol). This groundbreaking antibiotic was developed to address serious gram-negative bacterial infections, including those that are resistant to other medications. Its singular Trojan horse mechanism allows it to surmount multiple resistance obstacles, thereby providing a vital alternative for patients with limited treatment options.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cephalosporin-drugs-global-market-report
Which Is The Largest Region In The Cephalosporin Drugs Market?
North America was the largest region in the cephalosporin drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cephalosporin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cephalosporin Drugs Market?
2. What is the CAGR expected in the Cephalosporin Drugs Market?
3. What Are the Key Innovations Transforming the Cephalosporin Drugs Industry?
4. Which Region Is Leading the Cephalosporin Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Antimicrobial Resistance: A Significant Driver Propelling The Cephalosporin Drugs Market In 2025 here
News-ID: 4060569 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
